Literature DB >> 25239857

Prescription drug abuse: from epidemiology to public policy.

R Kathryn McHugh1, Suzanne Nielsen2, Roger D Weiss3.   

Abstract

Prescription drug abuse has reached an epidemic level in the United States. The prevalence of prescription drug abuse escalated rapidly beginning in the late 1990s, requiring a significant increase in research to better understand the nature and treatment of this problem. Since this time, a research literature has begun to develop and has provided important information about how prescription drug abuse is similar to, and different from the abuse of other substances. This introduction to a special issue of the Journal of Substance Abuse Treatment on prescription drug abuse provides an overview of the current status of the research literature in this area. The papers in this special issue include a sampling of the latest research on the epidemiology, clinical correlates, treatment, and public policy considerations of prescription drug abuse. Although much has been learned about prescription drug abuse in recent years, this research remains in early stages, particularly with respect to understanding effective treatments for this population. Future research priorities include studies on the interaction of prescription drugs with other licit and illicit substances, the impact of prescription drug abuse across the lifespan, the optimal treatment for prescription drug abuse and co-occurring conditions, and effective public policy initiatives for reducing prescription drug abuse.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epidemiology; Nonmedical drug use; Prescription drug abuse; Prescription opioids; Treatment

Mesh:

Year:  2014        PMID: 25239857      PMCID: PMC4250400          DOI: 10.1016/j.jsat.2014.08.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  79 in total

Review 1.  Psychoactive drug abuse in older adults.

Authors:  Linda Simoni-Wastila; Huiwen Keri Yang
Journal:  Am J Geriatr Pharmacother       Date:  2006-12

2.  Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence.

Authors:  Kelly S Barth; Megan Moran-Santa Maria; Katie Lawson; Stephanie Shaftman; Kathleen T Brady; Sudie E Back
Journal:  Am J Addict       Date:  2013-05-15

3.  Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.

Authors:  S S Martins; M C Fenton; K M Keyes; C Blanco; H Zhu; C L Storr
Journal:  Psychol Med       Date:  2011-10-17       Impact factor: 7.723

4.  Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; Margaret L Griffin; R Kathryn McHugh; Deborah Haller; Petra Jacobs; John Gardin; Dan Fischer; Kristen D Rosen
Journal:  J Subst Abuse Treat       Date:  2014-04-04

5.  Buprenorphine tapering schedule and illicit opioid use.

Authors:  Walter Ling; Maureen Hillhouse; Catherine Domier; Geetha Doraimani; Jeremy Hunter; Christie Thomas; Jessica Jenkins; Albert Hasson; Jeffrey Annon; Andrew Saxon; Jeffrey Selzer; Joshua Boverman; Richard Bilangi
Journal:  Addiction       Date:  2009-02       Impact factor: 6.526

6.  Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study.

Authors:  Jessica A Dreifuss; Margaret L Griffin; Katherine Frost; Garrett M Fitzmaurice; Jennifer Sharpe Potter; David A Fiellin; Jeffrey Selzer; Mary Hatch-Maillette; Susan C Sonne; Roger D Weiss
Journal:  Drug Alcohol Depend       Date:  2013-01-18       Impact factor: 4.492

7.  An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults.

Authors:  Scott H Kollins; Erin N Schoenfelder; Joseph S English; Alex Holdaway; Elizabeth Van Voorhees; Benjamin R O'Brien; Rachel Dew; Allan K Chrisman
Journal:  J Subst Abuse Treat       Date:  2014-08-07

8.  National trends in the office-based prescription of schedule II opioids.

Authors:  Mark Olfson; Shuai Wang; Miren Iza; Stephen Crystal; Carlos Blanco
Journal:  J Clin Psychiatry       Date:  2013-09       Impact factor: 4.384

9.  Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.

Authors:  Leonard J Paulozzi; Karin A Mack; Jason M Hockenberry
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-07-04       Impact factor: 17.586

10.  Understanding nonprescription and prescription drug misuse in late adolescence/young adulthood.

Authors:  Sasha A Fleary; Robert W Heffer; E Lisako J McKyer
Journal:  J Addict       Date:  2013-01-28
View more
  33 in total

1.  Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions - III.

Authors:  Bradley T Kerridge; Tulshi D Saha; S Patricia Chou; Haitao Zhang; Jeesun Jung; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2015-09-02       Impact factor: 4.492

2.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

3.  Multispecialty Opioid Risk Reduction Program Targeting Chronic Pain and Addiction Management in Veterans.

Authors:  Ivana A Vaughn; Rebecca Beyth; Mary Lynn Ayers; Joseph E Thornton; Rajiv Tandon; Ted Gingrich; Stephen A Mudra
Journal:  Fed Pract       Date:  2019-09

4.  Provider-patient communication about prescription drug abuse: A qualitative analysis of the perspective of prescribers.

Authors:  Stephanie M Mathis; Angela Hagaman; Nicholas Hagemeier; Katie Baker; Robert P Pack
Journal:  Subst Abus       Date:  2019-08-12       Impact factor: 3.716

5.  Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States.

Authors:  Sean Esteban McCabe; Timothy E Wilens; Carol J Boyd; Kao-Ping Chua; Terri Voepel-Lewis; Ty S Schepis
Journal:  Addict Behav       Date:  2018-11-14       Impact factor: 3.913

6.  Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder.

Authors:  R Kathryn McHugh; Victoria R Votaw; Olivera Bogunovic; Sterling L Karakula; Margaret L Griffin; Roger D Weiss
Journal:  Addict Behav       Date:  2016-08-18       Impact factor: 3.913

Review 7.  Prescription Opioid Misuse, Abuse, and Treatment in the United States: An Update.

Authors:  Kathleen T Brady; Jenna L McCauley; Sudie E Back
Journal:  Am J Psychiatry       Date:  2015-09-04       Impact factor: 18.112

8.  Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United States.

Authors:  Tulshi D Saha; Bradley T Kerridge; Risë B Goldstein; S Patricia Chou; Haitao Zhang; Jeesun Jung; Roger P Pickering; W June Ruan; Sharon M Smith; Boji Huang; Deborah S Hasin; Bridget F Grant
Journal:  J Clin Psychiatry       Date:  2016-06       Impact factor: 4.384

9.  Mycobacteremia from Crushed Hydromorphone Tablet Injection.

Authors:  Joseph M Banno; Katherine Shield; Krunal Patel; Anupam A Sule
Journal:  Cureus       Date:  2017-11-27

10.  Predictors and consequences of prescription drug misuse during middle school.

Authors:  Joan S Tucker; Brett A Ewing; Jeremy N V Miles; Regina A Shih; Eric R Pedersen; Elizabeth J D'Amico
Journal:  Drug Alcohol Depend       Date:  2015-09-26       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.